Nos publications
Compritol® 888 ATO vs Precirol® ATO 5 in hot melt extrusion: investigation of operating window limits
AAPS Annual Meeting and Exposition – San Diego (USA) - nov 2014
Ethanol resistant extended release matrix tablets with Compritol® 888 ATO
AAPS Annual Meeting and Exposition – San Diego (USA) - nov 2014
Effect of Tablet Structure on Controlled Release from Supersaturating Solid Dispersions Containing Glyceryl Behenate.
Mol. Pharmaceutics, 2015, 12 (1), pp 120–126 DOI: 10.1021/mp500480y - oct 2014
Estimating in vivo drug release from a new theophylline Compritol® 888 ATO matrix formulation using appropriate biorelevant test methods
CRS Annual Meeting – Chicago (USA) - jui 2014
Streamlining the design of sustained release matrix tablets using mathematical modeling for drug release optimization
CRS Annual Meeting – Chicago (USA) - jui 2014
Colour coating of Compritol® 888 ATO matrix tablets: a feasability study
AAPS Annual Meeting and Exposition – San Diego (USA) - 2014
Smart strategies for sustained release matrix tablets: Compritol® 888 ATO
OutsourcingPharma - mai 2014
This white paper gives an overview of how Compritol® 888 ATO provides clinically relevant sustained drug release profiles along with biopharmaceutical, formulation and manufacturing advantages.
Hot melt extrusion with Compritol® 888 ATO: determination of processing boundaries
PBP World Meeting – Vienna (Austria) - mar 2014
High Drug Load Lipid Matrix Tablets Prepared by Wet Granulation: PART II – Process Parameters
AAPS Annual Meeting and Exposition - San Antonio (USA) - nov 2013